Trial NCT01226745

View at ClinicalTrials.gov 
Org. Study IDs: ONO-4641POU007 (EMR200559-002)
Secondary IDs: 2010-018705-11

Last trial update was posted on 2016-07-12

MeSH Interventions

Ceralifimod

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions


Stopping Reasons

Merck has decided to not pursue phase 3 development of ceralifimod (ONO-4641). The decision was not related to any safety and efficacy findings

Limitations And Caveats

Company has decided to not pursue phase 3 development of ceralifimod (ONO-4641). The decision was not related to any safety and efficacy findings.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID